Signe Flottorp, research director at the Norwegian Institute of Public Health (FHI) sent a letter to the Norway's National Research Center in Complementary and Alternative Medicine (NAFKAM) in April this year, before the Dagbladet article. In the letter she asked them to retract and apologise for their, in Flottorp's view, erroneous risk assessment of Lightning Process.
She received an answer from Miek Jong, Head of Nafkam (who writes in English).
The Norwegian Directorate of Health were put on copy and the correspondence was thus available by a FOI request.
Attached are the letter from Flottorp with answer from Miek Jong and a google translated version of Flottorp's letter.
I see Miek Jong mentions the Virology Blog post. But she agrees with this clinical trial being done also. Even though it is designed to get positive findings.